Infusive Asset Management Inc. reduced its stake in Procter & Gamble Company (The) (NYSE:PG – Free Report) by 26.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,043 shares of the company’s stock after selling 20,558 shares during the period. Procter & Gamble accounts for 4.0% of Infusive Asset Management Inc.’s portfolio, making the stock its 10th largest position. Infusive Asset Management Inc.’s holdings in Procter & Gamble were worth $8,239,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Dickmeyer Boyce Financial Management Inc. bought a new stake in shares of Procter & Gamble during the 1st quarter valued at about $1,444,000. Gibbs Wealth Management boosted its holdings in shares of Procter & Gamble by 97.6% in the first quarter. Gibbs Wealth Management now owns 5,697 shares of the company’s stock worth $823,000 after buying an additional 2,814 shares during the last quarter. Sei Investments Co. grew its position in Procter & Gamble by 20.4% during the first quarter. Sei Investments Co. now owns 1,345,183 shares of the company’s stock valued at $194,299,000 after buying an additional 227,631 shares during the period. Keynote Financial Services LLC increased its holdings in Procter & Gamble by 6.8% during the first quarter. Keynote Financial Services LLC now owns 19,403 shares of the company’s stock valued at $2,803,000 after buying an additional 1,243 shares during the last quarter. Finally, Davis R M Inc. raised its position in Procter & Gamble by 2.7% in the first quarter. Davis R M Inc. now owns 329,437 shares of the company’s stock worth $47,584,000 after acquiring an additional 8,667 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Trading Down 1.5%
NYSE:PG opened at $146.94 on Friday. The stock has a fifty day simple moving average of $147.22 and a 200 day simple moving average of $148.71. The firm has a market capitalization of $342.16 billion, a price-to-earnings ratio of 21.48, a price-to-earnings-growth ratio of 7.42 and a beta of 0.39. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $167.25. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be given a dividend of $1.0885 per share. This represents a $4.35 annualized dividend and a yield of 3.0%. The ex-dividend date is Friday, July 24th. Procter & Gamble’s payout ratio is presently 63.60%.
Analysts Set New Price Targets
Several research analysts have recently weighed in on the stock. Barclays lifted their price target on shares of Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research note on Tuesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Wednesday, June 24th. Royal Bank Of Canada lowered their target price on Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating on the stock in a research report on Thursday, April 9th. TD Cowen upped their price target on Procter & Gamble from $142.00 to $150.00 and gave the stock a “hold” rating in a research report on Monday, April 27th. Finally, BMO Capital Markets raised their price objective on Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research note on Monday, June 29th. Twelve research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $161.74.
Check Out Our Latest Research Report on PG
Trending Headlines about Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Neutral Sentiment: Procter & Gamble is approaching Q4 earnings, and investors are watching for signs of continued sales growth, but also for evidence that cost pressures and tariffs are squeezing margins. Procter & Gamble to Report Q4 Earnings: What Should You Know?
- Neutral Sentiment: Analysts are warning that PG may report lower earnings, and the market appears cautious heading into the release because the setup does not clearly favor an earnings beat. Analysts Estimate Procter & Gamble (PG) to Report a Decline in Earnings: What to Look Out for
- Neutral Sentiment: Another preview piece echoed the same message: investors are waiting for Q4 results, with sales growth expected but margin and cost challenges still front and center. Procter & Gamble to Report Q4 Earnings: What Should You Know?
- Positive Sentiment: PG may still appeal to defensive investors if market volatility continues, with one article suggesting the consumer staples name could benefit as money rotates out of high-growth sectors. As the AI Selloff Worsens, Time-Tested Procter & Gamble Stock Could Be the Biggest Winner
- Positive Sentiment: Procter & Gamble also highlighted a new Swiffer Lemon Duster product, reinforcing its innovation pipeline and brand strength in household products. New Swiffer Lemon Duster Delivers Fresh Scent of Clean with No Spray Required
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also
- Five stocks we like better than Procter & Gamble
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
